Please login to the form below

Not currently logged in
Email:
Password:

licensing

This page shows the latest licensing news and features for those working in and with pharma, biotech and healthcare.

AZ cuts $1.5bn-plus deal to pass US drug rights to Sobi

AZ cuts $1.5bn-plus deal to pass US drug rights to Sobi

The licensing deal includes $1bn in cash, with AZ taking an 8% equity stake in Sobi for $500m, and will also see around 130 of AZ’s workers transferred to the ... The deal represents a major expansion for Sobi, which is currently focused on rare

Latest news

More from news
Approximately 7 fully matching, plus 600 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 5 fully matching, plus 82 partially matching documents found.

Latest appointments

  • Gamida Cell strengthens leadership team Gamida Cell strengthens leadership team

    He has also served as vice president, business and corporate development at Infinity Pharmaceuticals, where he was responsible for the company’s in-licensing, out-licensing and alliance management activities.

  • Neurimmune appoints chief business officer Neurimmune appoints chief business officer

    Dr Buller has an impressive track record in business development and licensing transactions.

  • Ipsen bolsters leadership team Ipsen bolsters leadership team

    Prior to this, she has served as senior vice president, head of global business development at Teva Pharmaceuticals, where she led and executed multiple business development transactions ranging from licensing to

  • Damien McDevitt moves from GSK to Acadia Pharmaceuticals Damien McDevitt moves from GSK to Acadia Pharmaceuticals

    Damien has extensive experience in business development, licensing and strategic partnering, and he has completed dozens of value-creating transactions.

  • Apeiron bolsters management board Apeiron bolsters management board

    With more than 25 years’experience in initial public offerings, mergers and acquisitions, as well as licensing and financial transactions in the chemical, biotech and pharma industries, Llewellyn-Davies most recently

More from appointments
Approximately 0 fully matching, plus 42 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 15 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics